Last reviewed · How we verify
SYHX1901
SYHX1901 is a small molecule drug that targets the molecular target.
SYHX1901 is a small molecule drug that targets the molecular target. Used for Indication 1.
At a glance
| Generic name | SYHX1901 |
|---|---|
| Sponsor | CSPC Ouyi Pharmaceutical Co., Ltd. |
| Target | molecular target |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of SYHX1901 is not well understood, but it is believed to work by interacting with the molecular target, leading to a specific therapeutic effect.
Approved indications
- Indication 1
Common side effects
- Common adverse event
Key clinical trials
- Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients (PHASE2)
- A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis (PHASE3)
- A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients (PHASE2)
- An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis (PHASE2)
- The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |